CRDF (Cardiff Oncology, Inc.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).
For Q2'26, revenue estimate is 62.78 thousand USD with EPS (earnings per share) anticipated at (0.12) USD. Learn more details at .
Revenue & EPS values are provided in USD
| Q2'25Q3'25Q4'25Q1'26Q2'26 | |||||
| Revenue Reported121.00 K120.00 K243.00 K41.00 K— | Revenue Estimate109.38 K125.00 K103.50 K88.57 K62.78 K | Revenue Surprise+10.63%-4.00%+134.78%-53.71% | EPS Reported(0.21)(0.17)(0.11)(0.18) | EPS Estimate(0.19)(0.20)(0.19)(0.13)(0.12) | EPS Surprise-9.09%+17.07%+41.80%-33.51% |